New York, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The global revenue from the perfusion bioreactors market is estimated to reach US$ 345.6 Million in 2022, with the global market growing at a 7.2% CAGR to ...

Recombinant adeno-associated virus (rAAV) is currently used as vector in about 250 clinical trials for gene therapy (Bulcha et al., 2021). Nonetheless, there are still several challenges concerning ...

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Perfusion Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...

Sartorius Stedim Biotech (SSB) said today it will integrate Repligen’s XCell™ ATF cell retention control technology into SSB’s BIOSTAT® STR large-scale single-use bioreactors to create novel perfusion ...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...

BANGALORE, India, Feb. 19, 2024 /PRNewswire/ -- Perfusion Bioreactor Market is Segmented by Type (Small Scale (Less Than 100 Liters), Mid-Scale (100 Liters to 1,000 Liters), Large Scale (More Than ...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, and Repligen Corporation, a global life sciences company focused on bioprocessing technologies, ...

Sartorius Stedim Biotech has launched a new automated parallel bioreactor system for perfusion culture. Sartorius Stedim Biotech (SSB), a supplier for the biopharmaceutical industry, has launched a ...

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc.

TAP Biosystems has announced that it will be co-presenting a new bioprocess webinar with Irvine Scientific, a major producer of cell culture media, on Wednesday March 12th 2014 at 9 am PST / 12 noon ...